Filter your results
- 3
- 1
- 4
- 4
- 1
- 1
- 2
- 4
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
IgG4-related disease in patients with idiopathic orbital inflammation syndrome: data from the French SIOI prospective cohortActa Ophthalmologica Scandinavica -Supplement-, 2019, ⟨10.1111/aos.13968⟩
Journal articles
hal-01987912v1
|
|||
|
Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: Multicenter study from the french uveitis networkArthritis & rheumatology, 2016, 66 (6), pp.1522-1530. ⟨10.1002/art.39667⟩
Journal articles
hal-01301142v1
|
||
|
Clinicopathologic characteristics, treatment, and outcomes of tubulointerstitial nephritis and uveitis syndrome in adults: A national retrospective strobe-compliant studyMedicine, 2016, 95 (26), pp.e3964. ⟨10.1097/MD.0000000000003964⟩
Journal articles
hal-01466052v1
|
||
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndromeAutoimmunity Reviews, 2018, 17 (12), pp.1153 - 1168. ⟨10.1016/j.autrev.2018.05.012⟩
Journal articles
hal-01936357v1
|